Bucio-Ortiz L, Enriquez-Navarro K, Maldonado-Rodriguez A, Torres-Flores J, Cevallos A, Salcedo M
Pathogens. 2024; 13(8).
PMID: 39204261
PMC: 11357063.
DOI: 10.3390/pathogens13080662.
Kim G, Choi S, Han S, Lim Y
Clin Mol Hepatol. 2024; 30(4):793-806.
PMID: 39026397
PMC: 11540400.
DOI: 10.3350/cmh.2024.0252.
Shin H, Choi W, Kim S, Ko Y, Park Y, Park J
JHEP Rep. 2024; 6(7):101089.
PMID: 38974365
PMC: 11225842.
DOI: 10.1016/j.jhepr.2024.101089.
Shin H, Lee H, Noh J, Koh J, Kim S, Park J
Immune Netw. 2023; 23(5):e39.
PMID: 37970236
PMC: 10643334.
DOI: 10.4110/in.2023.23.e39.
Bello K, Mat Jusoh T, Irekeola A, Abu N, Mohd Amin N, Mustaffa N
Healthcare (Basel). 2023; 11(7).
PMID: 37046937
PMC: 10094200.
DOI: 10.3390/healthcare11071011.
Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study.
Yun B, Ahn S, Yoon J, Kim B
Hepatol Commun. 2022; 6(9):2455-2464.
PMID: 35766457
PMC: 9426396.
DOI: 10.1002/hep4.2022.
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.
Choi W, Kim G, Choi J, Han S, Lim Y
J Clin Invest. 2022; 132(10).
PMID: 35358094
PMC: 9106348.
DOI: 10.1172/JCI154833.
rt269I Type of Hepatitis B Virus (HBV) Polymerase versus rt269L Is More Prone to Mutations within HBV Genome in Chronic Patients Infected with Genotype C2: Evidence from Analysis of Full HBV Genotype C2 Genome.
Jeong H, Kim D, Choi Y, Choi H, Kim D, Kim B
Microorganisms. 2021; 9(3).
PMID: 33803998
PMC: 7999911.
DOI: 10.3390/microorganisms9030601.
Reduced liver cancer mortality with regular clinic follow-up among patients with chronic hepatitis B: A nationwide cohort study.
Shim J, Kim G, Oh C, Kim J, Myung J, Kim B
Cancer Med. 2020; 9(20):7781-7791.
PMID: 32857923
PMC: 7571840.
DOI: 10.1002/cam4.3421.
The characteristic of the synonymous codon usage and phylogenetic analysis of hepatitis B virus.
Qi X, Wei C, Li Y, Wu Y, Xu H, Guo R
Genes Genomics. 2020; 42(7):805-815.
PMID: 32462516
PMC: 7311504.
DOI: 10.1007/s13258-020-00932-w.
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase.
Lee H, Kim E, Lee J, Kim S, Park J, Kim D
Clin Transl Gastroenterol. 2020; 11(3):e00140.
PMID: 32352711
PMC: 7145045.
DOI: 10.14309/ctg.0000000000000140.
Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B.
Kim G, Shim J, Lee J, Kim B, Kim J, Oh C
Yonsei Med J. 2019; 60(12):1203-1208.
PMID: 31769252
PMC: 6881704.
DOI: 10.3349/ymj.2019.60.12.1203.
rt269I Type of Hepatitis B Virus (HBV) Leads to HBV e Antigen Negative Infections and Liver Disease Progression via Mitochondrial Stress Mediated Type I Interferon Production in Chronic Patients With Genotype C Infections.
Lee S, Choi Y, Oh S, Yang S, Lee J, Choe W
Front Immunol. 2019; 10:1735.
PMID: 31402915
PMC: 6677150.
DOI: 10.3389/fimmu.2019.01735.
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals.
Lee H, Kim S, Park J, Baatarkhuu O, Kim D, Ahn S
Clin Transl Gastroenterol. 2019; 10(6):e00036.
PMID: 31107725
PMC: 6613858.
DOI: 10.14309/ctg.0000000000000036.
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals.
Lee H, Kim S, Baatarkhuu O, Park J, Kim D, Ahn S
Sci Rep. 2019; 9(1):2508.
PMID: 30792468
PMC: 6385334.
DOI: 10.1038/s41598-019-39043-2.
Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study.
Kim S, Jang E, Ki M, Gwak G, Kim K, Kim G
J Korean Med Sci. 2018; 33(42):e264.
PMID: 30310365
PMC: 6179986.
DOI: 10.3346/jkms.2018.33.e264.
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
Choi J, Kim H, Lee J, Cho S, Ko M, Lim Y
JAMA Oncol. 2018; 5(1):30-36.
PMID: 30267080
PMC: 6439769.
DOI: 10.1001/jamaoncol.2018.4070.
Large-scale surveillance study of the safety and effectiveness of entecavir in Korean patients with chronic hepatitis B.
Kim C, Kim C, Kim H, Lee C, Yu K, Llamoso C
Korean J Intern Med. 2017; 33(1):91-101.
PMID: 29228519
PMC: 5768541.
DOI: 10.3904/kjim.2016.111.
Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B.
Choe J, Ko J, Choe B, Kim J, Kang B, Lee K
J Korean Med Sci. 2017; 33(2):e11.
PMID: 29215820
PMC: 5729652.
DOI: 10.3346/jkms.2018.33.e11.
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.
Lee K, Kweon Y, Um S, Kim B, Lim Y, Paik S
Clin Mol Hepatol. 2017; 23(4):331-339.
PMID: 28946736
PMC: 5760004.
DOI: 10.3350/cmh.2016.0040.